Vaccines are one of the most effective public health interventions in history, preventing an estimated 2–3 million deaths annually. Routine childhood immunization protects against 14 serious diseases and has dramatically reduced the incidence of vaccine-preventable diseases.

How Vaccines Work
Vaccines stimulate the immune system to produce an adaptive immune response without causing the disease itself. They contain antigens — weakened or inactivated pathogens, specific subunits, or genetic material encoding antigens. The immune system responds by producing antibodies (B cells) and memory T cells. Upon subsequent exposure to the actual pathogen, the memory response rapidly neutralizes the threat, preventing or reducing the severity of disease.
Types of vaccines. Live attenuated vaccines (MMR, varicella, rotavirus, yellow fever, intranasal influenza) use weakened live viruses that replicate but do not cause disease in immunocompetent hosts. Inactivated vaccines (IPV, hepatitis A, rabies, most influenza) use killed pathogens. Subunit, recombinant, and conjugate vaccines (Hib, pneumococcal, HPV, hepatitis B, acellular pertussis, meningococcal) use purified antigens. Toxoid vaccines (tetanus, diphtheria) use inactivated toxins. mRNA vaccines (COVID-19) use genetic material encoding the spike protein to trigger an immune response.
Routine Childhood Immunization Schedule
The CDC and AAP recommend a standardized schedule that begins at birth and continues through adolescence.

Birth. Hepatitis B (first dose).
2 months. Hepatitis B (second dose), rotavirus, DTaP (diphtheria, tetanus, acellular pertussis), Hib (Haemophilus influenzae type b), PCV13 (pneumococcal conjugate), IPV (inactivated polio).
4 months. Rotavirus, DTaP, Hib, PCV13, IPV.
6 months. Hepatitis B (third dose), rotavirus, DTaP, Hib, PCV13, IPV, annual influenza vaccine (first dose — two doses needed in the first season).
12–15 months. MMR (measles, mumps, rubella), varicella, Hib (booster), PCV13 (booster), hepatitis A (first dose, second dose at 18 months).
18 months. DTaP (booster).
4–6 years. DTaP (booster), IPV (booster), MMR (second dose), varicella (second dose).
11–12 years. Tdap (tetanus, diphtheria, acellular pertussis), HPV (human papillomavirus, two doses if started before 15 years), MenACWY (meningococcal conjugate). Annual influenza vaccine continues through life.
16 years. MenB (meningococcal B, shared clinical decision-making). COVID-19 vaccine (as recommended).
Herd Immunity
Herd immunity (community immunity) occurs when a sufficient proportion of the population is immune to a pathogen, interrupting transmission. This protects individuals who cannot be vaccinated — infants, immunocompromised patients, pregnant women, and those with medical contraindications. The herd immunity threshold varies by pathogen: measles requires 95% coverage (highly contagious, R₀=12–18); polio requires 80–85% (R₀=5–7); influenza requires 33–44% (R₀=1.5–1.8). When vaccination rates fall below the threshold, outbreaks occur — measles resurgence in the US and Europe in recent years is directly linked to declining vaccination rates.
Addressing Vaccine Hesitancy
Vaccine hesitancy — delay in acceptance or refusal of vaccines despite availability — is a growing global health threat. The WHO listed it as one of the top 10 global health threats in 2019. Effective communication strategies: listen to concerns respectfully without dismissing them. Use presumptive language (We need to do vaccines today). Emphasize the benefits of vaccination and the risks of the diseases. Address specific concerns with factual information. Use personal stories and acknowledge uncertainty when appropriate. Maintain trust through continuity of care.
Summary
Childhood vaccination is the cornerstone of preventive pediatrics. The routine immunization schedule protects against 14 diseases through a carefully timed sequence of vaccines. Vaccines are safe and effective. Herd immunity protects vulnerable populations. Declining vaccination rates threaten public health gains. Healthcare providers play a crucial role in maintaining trust in vaccines.